Clinical Trial Update: A Study of Dotinurad Versus Allopurinol in Tophaceous Gout [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial comparing dotinurad to allopurinol for tophaceous gout is currently recruiting, sponsored by Crystalys Therapeutics.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Gout

Drugs mentioned

• Allopurinol (Allopurinol)
• Dotinurad (dotinurad)

Snippet

Sponsor: Crystalys Therapeutics | Conditions: Tophaceous Gout | Phase 3 | Status: RECRUITING